Insider transactions

EDGAR

STARLING ONCOLOGY, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
17 transactions, 838,208 shares
Sum of shares × price per share: 2,862,308.59
Open-market sales (code S)
9 transactions, 3,306,116 shares
Sum of shares × price per share: 13,984,780.4311

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 74

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-12 Filed 2026-11-17Podnos Yale Officer: Chief Medical Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)7703.76
2,895.2

Derived: shares × price per share. Exact value 2895.20.

258,757Direct (D) No
F1
  • F1 Reflects shares required to be sold pursuant to a sell-to-cover transaction in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units, mandated by the Issuer and does not reflect a discretionary trade by the Reporting Person.
Open filing 0001079973-26-001545 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 19FEB27 $4C) — underlying Common Stock (139,100) — exercise price 4
Acquired (A)1,3910.80
1,112.8

Derived: shares × price per share. Exact value 1112.80.

6,391Direct (D) No
F1
  • F1 The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer.
Open filing 0001193805-26-001470 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-12Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 19FEB27 $4C) — underlying Common Stock (139,100) — exercise price 4
Acquired (A)1,3910.80
1,112.8

Derived: shares × price per share. Exact value 1112.80.

6,391Direct (D) No
F1
  • F1 The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer.
Open filing 0001193805-26-001455 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 21MAY27 $5C) — underlying Common Stock (700,000) — exercise price 5
Acquired (A)7,0000.67
4,690

Derived: shares × price per share. Exact value 4690.00.

7,000Direct (D) No
F2
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-10Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)48,2943.65
176,273.1

Derived: shares × price per share. Exact value 176273.10.

7,858,091Direct (D) No
F2, F3
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
  • F3 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-10Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 19FEB27 $5C) — underlying Common Stock (750,000) — exercise price 5
Acquired (A)7,5000.5357
4,017.75

Derived: shares × price per share. Exact value 4017.7500.

7,500Direct (D) No
F2, F4
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
  • F4 The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Chernett Jorey 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,851,0613.99
11,375,733.39

Derived: shares × price per share. Exact value 11375733.39.

7,809,797Direct (D) No
F1, F2
  • F1 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 20NOV26 $4C) — underlying Common Stock (1,000,000) — exercise price 4
Acquired (A)10,0000.075
750

Derived: shares × price per share. Exact value 750.000.

10,000Direct (D) No
F2
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Call Option (STLN 19FEB27 $4C) — underlying Common Stock (500,000) — exercise price 4
Acquired (A)5,0000.40
2,000

Derived: shares × price per share. Exact value 2000.00.

5,000Direct (D) No
F2
  • F2 The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Open filing 0000921895-26-003018 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-24Hively Brad Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)298,8536.5126
1,946,310.0478

Derived: shares × price per share. Exact value 1946310.0478.

411,976Direct (D) Yes
F1
  • F1 Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.37 to $6.75 per share. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.
Open filing 0001079973-26-001175 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,0006.54
78,480

Derived: shares × price per share. Exact value 78480.00.

10,660,858Direct (D) No— Open filing 0000921895-26-002203 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-17Chernett Jorey 10% owner
S

Open market or private sale of non-derivative or derivative security

Derivative security: Call Option (STLN 19FEB27 $9C) — underlying Common Stock (10,000) — exercise price 9
Disposed (D)1006.24
624

Derived: shares × price per share. Exact value 624.00.

0Direct (D) No
F1
  • F1 The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Open filing 0000921895-26-002203 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Pacala Mark L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)30,1200.00
0

Derived: shares × price per share. Exact value 0.00.

286,881Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000989 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29STOLPER MARK Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)31,1240.00
0

Derived: shares × price per share. Exact value 0.00.

56,957Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000987 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29McGeorge Anne Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)41,1650.00
0

Derived: shares × price per share. Exact value 0.00.

332,535Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000991 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Hively Brad Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)27,1080.00
0

Derived: shares × price per share. Exact value 0.00.

710,829Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000983 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Kaushal Mohit Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)33,1330.00
0

Derived: shares × price per share. Exact value 0.00.

205,716Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000993 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Johnson Karen Marie Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)31,1240.00
0

Derived: shares × price per share. Exact value 0.00.

319,410Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000981 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29TZOUMAKAS KIMBERLY JO Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)29,1160.00
0

Derived: shares × price per share. Exact value 0.00.

46,301Direct (D) No
F1
  • F1 Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Open filing 0001079973-26-000985 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-22Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)18,0005.27
94,860

Derived: shares × price per share. Exact value 94860.00.

10,648,858Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.28, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Open filing 0000921895-26-001852 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)17,9741.87
33,611.38

Derived: shares × price per share. Exact value 33611.38.

277,501Direct (D) Yes— Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,9746.429
115,554.846

Derived: shares × price per share. Exact value 115554.846.

259,527Direct (D) Yes
F1, F3
  • F1 The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025.
  • F3 The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1.
Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,4782.00
10,956

Derived: shares × price per share. Exact value 10956.00.

265,005Direct (D) Yes— Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,4786.35
34,785.3

Derived: shares × price per share. Exact value 34785.30.

259,527Direct (D) Yes
F1, F3
  • F1 The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025.
  • F3 The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1.
Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (17,974) — exercise price 1.87
Acquired (A)17,9741.87
33,611.38

Derived: shares × price per share. Exact value 33611.38.

0Direct (D) Yes
F2
  • F2 The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms.
Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Podnos Yale Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,478) — exercise price 2.00
Acquired (A)5,4782.00
10,956

Derived: shares × price per share. Exact value 10956.00.

0Direct (D) Yes
F2
  • F2 The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms.
Open filing 0001553350-26-000111 Read from the filing’s XML Dispute this row
2026-07-10 Filed 2026-07-13Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,0005.85
87,750

Derived: shares × price per share. Exact value 87750.00.

10,630,858Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Open filing 0000921895-26-001798 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09STOLPER MARK Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,8330.00
0

Derived: shares × price per share. Exact value 0.00.

25,833Direct (D) No
F1
  • F1 Represents RSU award that was fully vested upon grant.
Open filing 0001079973-26-000939 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09TZOUMAKAS KIMBERLY JO Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)17,1850.00
0

Derived: shares × price per share. Exact value 0.00.

17,185Direct (D) No
F1
  • F1 Represents RSU award that was fully vested upon grant
Open filing 0001079973-26-000940 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)18,0005.02
90,360

Derived: shares × price per share. Exact value 90360.00.

10,615,858Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.04, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Open filing 0000921895-26-001657 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-09Podnos Yale Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,4515.3769
126,093.6819

Derived: shares × price per share. Exact value 126093.6819.

259,527Direct (D) Yes
F1, F2
  • F1 Price is the volume weighted average selling price of all sales on behalf of the Reporting Person on June 8, 2028 within a one-dollar range. Actual prices ranged from $5.35 to $5.42. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
  • F2 Sales were made on behalf of the Reporting Person pursuant to the Rule 10b5-1(c) plan that was adopted on 08/26/2025.
Open filing 0001079973-26-000801 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,0004.75
57,000

Derived: shares × price per share. Exact value 57000.00.

10,579,858Direct (D) No— Open filing 0000921895-26-001564 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-22Virnich Daniel Officer: Chief Executive Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)23,0584.47
103,069.26

Derived: shares × price per share. Exact value 103069.26.

2,337,166Direct (D) No
F1
  • F1 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.
Open filing 0001079973-26-000725 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-22Podnos Yale Officer: Chief Medical Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)1,8054.47
8,068.35

Derived: shares × price per share. Exact value 8068.35.

282,978Direct (D) No
F1
  • F1 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.
Open filing 0001079973-26-000727 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-22Carter Robert Ross Officer: Chief Financial Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)1,6044.47
7,169.88

Derived: shares × price per share. Exact value 7169.88.

414,801Direct (D) No
F1
  • F1 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024.
Open filing 0001079973-26-000723 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-21Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)33,5004.07
136,345

Derived: shares × price per share. Exact value 136345.00.

10,567,858Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Open filing 0000921895-26-001466 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0004.05
20,250

Derived: shares × price per share. Exact value 20250.00.

10,534,358Direct (D) No— Open filing 0000921895-26-001466 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)30,0004.09
122,700

Derived: shares × price per share. Exact value 122700.00.

10,529,358Direct (D) No— Open filing 0000921895-26-001444 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-16Kaushal Mohit Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)38,4333.5005
134,534.7165

Derived: shares × price per share. Exact value 134534.7165.

172,583Direct (D) Yes
F1, F3
  • F1 Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025.
  • F3 Price of $3.5005 was the volume weighted average selling price of all sales by the reporting person on April 16, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5050. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Open filing 0001079973-26-000499 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-16Kaushal Mohit Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)57,2863.5017
200,598.3862

Derived: shares × price per share. Exact value 200598.3862.

211,016Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025.
  • F2 Price of $3.5017 was the volume weighted average selling price of all sales by the reporting person on April 14, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5300. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Open filing 0001079973-26-000499 Read from the filing’s XML Dispute this row
2026-04-09 Filed 2026-04-13Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0003.10
62,000

Derived: shares × price per share. Exact value 62000.00.

10,499,358Direct (D) No— Open filing 0000921895-26-000958 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Langsam Jeffrey Officer: Chief Clinical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)70,2700—127,650Direct (D) No
F1
  • F1 Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Open filing 0001079973-26-000449 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Virnich Daniel Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)670,6080—2,458,758Direct (D) No
F1
  • F1 Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Open filing 0001079973-26-000439 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Virnich Daniel Officer: Chief Executive Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)98,5343.07
302,499.38

Derived: shares × price per share. Exact value 302499.38.

2,360,224Direct (D) No
F2
  • F2 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.
Open filing 0001079973-26-000439 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Podnos Yale Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)66,4460—300,956Direct (D) No
F1
  • F1 Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Open filing 0001079973-26-000443 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Podnos Yale Officer: Chief Medical Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)16,1733.07
49,651.11

Derived: shares × price per share. Exact value 49651.11.

284,783Direct (D) No
F2
  • F2 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.
Open filing 0001079973-26-000443 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01England Kristin Officer: Chief Administrative Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)55,7430—153,780Direct (D) No
F1
  • F1 Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates
Open filing 0001079973-26-000447 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Carter Robert Ross Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)202,9140—436,725Direct (D) No
F1
  • F1 Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Open filing 0001079973-26-000440 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-04-01Carter Robert Ross Officer: Chief Financial Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)20,3203.07
62,382.4

Derived: shares × price per share. Exact value 62382.40.

416,405Direct (D) No
F2
  • F2 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026
Open filing 0001079973-26-000440 Read from the filing’s XML Dispute this row
2026-03-27 Filed 2026-03-30Chernett Jorey 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)27,4292.96
81,189.84

Derived: shares × price per share. Exact value 81189.84.

10,479,358Direct (D) No— Open filing 0000921895-26-000823 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 154

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager5,327,532 SH33,670,003 dollarsHigher by 578,502 Prior quarter: 4,749,030Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
DEERFIELD MANAGEMENT COMPANY, L.P. Partly reported under another manager4,610,052 SH21,296,529 dollarsUnchanged Prior quarter: 4,610,052Open filing 0001213900-26-120609 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,471,514 SH21,939,968 dollarsHigher by 205,983 Prior quarter: 3,265,531Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager2,497,000 SH15,781,040 dollarsHigher by 1,727,800 Prior quarter: 769,200Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2,493,109 SH15,756,449 dollarsHigher by 28,750 Prior quarter: 2,464,359Open filing 0001911348-26-000006 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,111,736 SH13,349,695 dollarsHigher by 211,738 Prior quarter: 1,899,998Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager2,026,600 SH12,808,112 dollarsHigher by 506,500 Prior quarter: 1,520,100Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager1,980,919 SH12,519,408 dollarsHigher by 1,270,031 Prior quarter: 710,888Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager1,978,307 SH12,502,900 dollarsHigher by 425,390 Prior quarter: 1,552,917Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
WEXFORD CAPITAL LP 1,711,323 SH10,815,561 dollarsUnchanged Prior quarter: 1,711,323Open filing 0001398344-26-020059 Filed 2026-11-13 Dispute this row
LMR Partners LLP Partly reported under another manager1,624,856 SH79,293 dollarsUnchanged Prior quarter: 1,624,856Open filing 0001578621-26-000193 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,203,272 SH7,604,679 dollarsLower by 532,065 Prior quarter: 1,735,337Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager1,178,277 SH7,446,711 dollarsLower by 187,636 Prior quarter: 1,365,913Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
FMR LLC Partly reported under another manager1,139,452 SH7,201,337 dollarsHigher by 1,061,345 Prior quarter: 78,107Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,052,364 SH6,650,940 dollarsHigher by 45,327 Prior quarter: 1,007,037Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager992,853 SH6,274,831 dollarsHigher by 98,752 Prior quarter: 894,101Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager962,202 SH6,081,116 dollarsLower by 446,518 Prior quarter: 1,408,720Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
TWO SIGMA INVESTMENTS, LP 858,198 SH5,423,811 dollarsHigher by 189,359 Prior quarter: 668,839Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager762,257 SH4,813 dollarsHigher by 195,256 Prior quarter: 567,001Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
BRC Group Holdings, Inc. 722,381 SH4,565,448 dollarsLower by 20,212 Prior quarter: 742,593Open filing 0001213900-26-119878 Filed 2026-11-13 Dispute this row
Informed Momentum Co LLC 718,398 SH4,540,275 dollarsHigher by 529,931 Prior quarter: 188,467Open filing 0001104659-26-127619 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager630,690 SH3,985,961 dollarsHigher by 39,156 Prior quarter: 591,534Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 625,522 SH3,953,299 dollarsHigher by 528,647 Prior quarter: 96,875Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 600,868 SH3,797,486 dollarsHigher by 98,819 Prior quarter: 502,049Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager534,854 SH3,380,276 dollarsLower by 687,644 Prior quarter: 1,222,498Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
Manatuck Hill Partners, LLC 525,000 SH3,318,000 dollarsHigher by 75,000 Prior quarter: 450,000Open filing 0001467902-26-000005 Filed 2026-11-16 Dispute this row
WOLVERINE ASSET MANAGEMENT LLC Partly reported under another manager467,099 SH22,794 dollarsHigher by 48,885 Prior quarter: 418,214Open filing 0001279891-26-000016 Filed 2026-11-02 Dispute this row
MORGAN STANLEY Partly reported under another manager426,298 SH2,694,204 dollarsHigher by 291,213 Prior quarter: 135,085Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager416,498 SH2,632,267 dollarsHigher by 389,673 Prior quarter: 26,825Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 411,629 SH2,601,495 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager393,655 SH2,487,900 dollarsHigher by 320,793 Prior quarter: 72,862Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
FORMULA GROWTH LTD 368,400 SH2,328,288 dollarsHigher by 68,400 Prior quarter: 300,000Open filing 0001011438-26-000699 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager367,846 SH2,394,677 dollarsLower by 41,502 Prior quarter: 409,348Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager360,400 SH2,277,728 dollarsLower by 94,900 Prior quarter: 455,300Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager345,421 SH2,397,222 dollarsHigher by 323,244 Prior quarter: 22,177Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Panoramic Capital, LLC 327,835 SH2,071,917 dollarsHigher by 227,835 Prior quarter: 100,000Open filing 0001950490-26-000009 Filed 2026-11-16 Dispute this row
Davidson Kempner Capital Management LP 318,710 SH15,553 dollarsUnchanged Prior quarter: 318,710Open filing 0001595082-26-000111 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager296,052 SH1,871,048 dollarsLower by 95,945 Prior quarter: 391,997Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager267,953 SH1,693,463 dollarsLower by 74,213 Prior quarter: 342,166Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
TORONTO DOMINION BANK Partly reported under another manager262,364 SH482,153 dollarsHigher by 74,890 Prior quarter: 187,474Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row
Walleye Capital LLC 258,898 SH1,636,235 dollarsLower by 186,934 Prior quarter: 445,832Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 226,124 SH1,429,104 dollarsHigher by 117 Prior quarter: 226,007Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Mount Lucas Management LP 200,000 SH1,264,000 dollarsLower by 50,000 Prior quarter: 250,000Open filing 0001140361-26-042664 Filed 2026-11-09 Dispute this row
GROUP ONE TRADING LLC Option: Call 189,000 SH1,194,480 dollarsLower by 71,700 Prior quarter: 260,700Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager181,971 SH1,150,056 dollarsHigher by 5,022 Prior quarter: 176,949Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
UBS Group AG Partly reported under another manager169,520 SH970,309 dollarsLower by 868 Prior quarter: 170,388Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
STEMPOINT CAPITAL LP 156,663 SH990,110 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 155,933 SH985,497 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Creative Planning Partly reported under another manager141,507 SH894,323 dollarsHigher by 31,582 Prior quarter: 109,925Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager137,688 SH870,188 dollarsHigher by 116,227 Prior quarter: 21,461Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CenterBook Partners LP 1,241,660 SH
  • JANE STREET GROUP, LLC 852,163 SH
  • Inspire Investing, LLC 424,008 SH
  • SG Americas Securities, LLC 263,147 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 233,379 SH
  • Sixth Street Partners Management Company, L.P. 226,007 SH
  • Oasis Management Co Ltd. 100,000 SH
  • GSA CAPITAL PARTNERS LLP 98,727 SH
  • EntryPoint Capital, LLC 44,972 SH
  • Innovative Asset Advisors Group, LLC 36,000 SH
  • ExodusPoint Capital Management, LP 33,644 SH
  • AXQ CAPITAL, LP 22,460 SH
  • INTECH INVESTMENT MANAGEMENT LLC 20,531 SH
  • Jump Financial, LLC 12,300 SH
  • R Squared Ltd 11,482 SH
  • ProShare Advisors LLC 10,026 SH
  • Kemnay Advisory Services Inc. 8,592 SH
  • Integrated Wealth Concepts LLC 334 SH
  • MERCER GLOBAL ADVISORS INC /ADV 256 SH
  • Quarry LP 155 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Chernett Jorey Common Stock, $0.001 Par Value Per Share5.65,934,872.0011/13/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 2Open filing 0001193805-26-001476 Dispute this row
M33 Growth I L.P. Common Stock, par value $0.0001 per share4.945,002,656.0005/14/2026 Filed 2026-05-15SCHEDULE 13D/AAmendment 6Open filing 0001213900-26-057832 Dispute this row
M33 Growth I GP LLC Common Stock, par value $0.0001 per share4.945,002,656.0005/14/2026 Filed 2026-05-15SCHEDULE 13D/AAmendment 6Open filing 0001213900-26-057832 Dispute this row
TOI M, LLC Common Stock, par value $0.0001 per share0.000.0005/14/2026 Filed 2026-05-15SCHEDULE 13D/AAmendment 6Open filing 0001213900-26-057832 Dispute this row
Chernett Jorey Common Stock, $0.0001 Par Value Per Share10.210,115,944.0003/13/2026 Filed 2026-03-16SCHEDULE 13G/AAmendment 1Open filing 0001193805-26-000263 Dispute this row
Chernett Jorey Common5.25,114,944.0001/14/2026 Filed 2026-01-15SCHEDULE 13GOpen filing 0002042077-26-000003 Dispute this row
M33 Growth I LP Common Stock, par value $0.0001 per share5.466,802,656.0011/18/2025 Filed 2025-11-20SCHEDULE 13D/AAmendment 5Open filing 0001213900-25-113108 Dispute this row
M33 Growth I GP LLC Common Stock, par value $0.0001 per share5.466,802,656.0011/18/2025 Filed 2025-11-20SCHEDULE 13D/AAmendment 5Open filing 0001213900-25-113108 Dispute this row
TOI M, LLC Common Stock, par value $0.0001 per share0.000.0011/18/2025 Filed 2025-11-20SCHEDULE 13D/AAmendment 5Open filing 0001213900-25-113108 Dispute this row
M33 Growth I LP Common Stock, par value $0.0001 per share9.799,290,838.0009/04/2025 Filed 2025-09-05SCHEDULE 13D/AAmendment 4Open filing 0001213900-25-085013 Dispute this row
M33 Growth I GP LLC Common Stock, par value $0.0001 per share9.799,290,838.0009/04/2025 Filed 2025-09-05SCHEDULE 13D/AAmendment 4Open filing 0001213900-25-085013 Dispute this row
TOI M, LLC Common Stock, par value $0.0001 per share0.63590,892.0009/04/2025 Filed 2025-09-05SCHEDULE 13D/AAmendment 4Open filing 0001213900-25-085013 Dispute this row
FOG Ventures Investments, LLC Common Stock, par value $0.0001 per share00.0005/15/2025 Filed 2025-06-24SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-062224 Dispute this row
Daniel Murillo Common Stock, par value $0.0001 per share00.0005/15/2025 Filed 2025-06-24SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-062224 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,540,664 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to STARLING ONCOLOGY, INC.